Cargando…
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
The immune system can both promote and suppress cancer. Chronic inflammation and proinflammatory cytokines such as interleukin (IL)-1 and IL-6 are considered to be tumour promoting. In contrast, the exact nature of protective antitumour immunity remains obscure. Here, we quantify locally secreted cy...
Autores principales: | Haabeth, Ole Audun Werner, Lorvik, Kristina Berg, Hammarström, Clara, Donaldson, Ian M., Haraldsen, Guttorm, Bogen, Bjarne, Corthay, Alexandre |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072106/ https://www.ncbi.nlm.nih.gov/pubmed/21407206 http://dx.doi.org/10.1038/ncomms1239 |
Ejemplares similares
-
Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2015) -
Molecular profiling of tumor-specific T(H)1 cells activated in vivo
por: Lorvik, Kristina Berg, et al.
Publicado: (2013) -
A model for cancer-suppressive inflammation
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2012) -
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
por: Haabeth, Ole Audun Werner, et al.
Publicado: (2014) -
Tumor-specific CD4(+) T cells eradicate myeloma cells genetically deficient in MHC class II display
por: Tveita, Anders, et al.
Publicado: (2016)